WCN26-297 FROM RESISTANCE TO REMISSION : CLINICAL OUTCOMES OF NUTRACEUTICAL THERAPY IN PYELONEPHRITIS

Read full text Summarise with VIRAT
Authors: Tahir Shaikh
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pyelonephritis in chronic kidney disease (CKD) patients is increasingly complicated by multidrug-resistant (MDR) Escherichia coli infections. These infections often resist standard allopathic treatments, necessitating exploration of integrative, non-antibiotic options. Nutraceuticals have emerged as promising adjuncts due to their antimicrobial and anti-adhesive properties.

Fields of Study & Subjects

Urinary Tract Infections Management Kidney Stones and Urolithiasis Treatments Essential Oils and Antimicrobial Activity

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104095–104095
Publication date
25 March 2026
Language
EN